Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Nat Commun ; 15(1): 7560, 2024 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-39215014

RESUMO

Due to low success rates and long cycles of traditional drug development, the clinical tendency is to apply omics techniques to reveal patient-level disease characteristics and individualized responses to treatment. However, the heterogeneous form of data and uneven distribution of targets make drug discovery and precision medicine a non-trivial task. This study takes pyroptosis therapy for triple-negative breast cancer (TNBC) as a paradigm and uses data mining of a large TNBC cohort and drug databases to establish a biofactor-regulated neural network for rapidly screening and optimizing compound pyroptosis drug pairs. Subsequently, biomimetic nanococrystals are prepared using the preferred combination of mitoxantrone and gambogic acid for rational drug delivery. The unique mechanism of obtained nanococrystals regulating pyroptosis genes through ribosomal stress and triggering pyroptosis cascade immune effects are revealed in TNBC models. In this work, a target omics-based intelligent compound drug discovery framework explores an innovative drug development paradigm, which repurposes existing drugs and enables precise treatment of refractory diseases.


Assuntos
Descoberta de Drogas , Piroptose , Neoplasias de Mama Triplo Negativas , Neoplasias de Mama Triplo Negativas/tratamento farmacológico , Neoplasias de Mama Triplo Negativas/metabolismo , Neoplasias de Mama Triplo Negativas/genética , Neoplasias de Mama Triplo Negativas/patologia , Humanos , Piroptose/efeitos dos fármacos , Feminino , Descoberta de Drogas/métodos , Animais , Mitoxantrona/farmacologia , Mitoxantrona/uso terapêutico , Xantonas/farmacologia , Linhagem Celular Tumoral , Antineoplásicos/farmacologia , Antineoplásicos/uso terapêutico , Camundongos , Inteligência Artificial , Mineração de Dados , Redes Neurais de Computação
2.
Artigo em Inglês | MEDLINE | ID: mdl-38669166

RESUMO

The conventional approach to image recognition has been based on raster graphics, which can suffer from aliasing and information loss when scaled up or down. In this paper, we propose a novel approach that leverages the benefits of vector graphics for object localization and classification. Our method, called YOLaT (You Only Look at Text), takes the textual document of vector graphics as input, rather than rendering it into pixels. YOLaT builds multi-graphs to model the structural and spatial information in vector graphics and utilizes a dual-stream graph neural network (GNN) to detect objects from the graph. However, for real-world vector graphics, YOLaT only models in flat GNN with vertexes as nodes ignore higher-level information of vector data. Therefore, we propose YOLaT++ to learn Multi-level Abstraction Feature Learning from a new perspective: Primitive Shapes to Curves and Points. On the other hand, given few public datasets focus on vector graphics, data-driven learning cannot exert its full power on this format. We provide a large-scale and challenging dataset for Chart-based Vector Graphics Detection and Chart Understanding, termed VG-DCU, with vector graphics, raster graphics, annotations, and raw data drawn for creating these vector charts. Experiments show that the YOLaT series outperforms both vector graphics and raster graphics-based object detection methods on both subsets of VG-DCU in terms of both accuracy and efficiency, showcasing the potential of vector graphics for image recognition tasks. Our codes, models, and the VG-DCU dataset are available at: https://github.com/microsoft/YOLaT-VectorGraphicsRecognition.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA